Aardvark Therapeutics, Inc. Common Stock
NASDAQ:AARDBiotechnology
Healthcare
$3.95 +2.36%
+$0.09 today
- Market cap
- $86.45M
- Beta
- 4.47
- P/E (TTM)
- -1.2
- EPS (TTM)
- -$3.20
52W Low $3.35High $17.94
Volume 1.32M
Average 0.18M
Price history
Aardvark Therapeutics, Inc. Common Stock SEC filings
Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.
Price history
Dividend-adjusted closing price
Period change
-62.24%
Period high
$15.82
Period low
$3.48
Latest
$3.95
SEC filings
What has the company disclosed?
Browse annual, quarterly, and current reports and other filings by form type.
SEC Filings
Recent regulatory filings
| Form | Filing Date | Accepted | |
|---|---|---|---|
| 3 | Oct 8, 2026 | Oct 8, 2026 | |
| 4 | Oct 8, 2026 | Oct 8, 2026 | |
| 8-K | Oct 8, 2026 | Oct 8, 2026 | |
| 4 | Sep 11, 2026 | Sep 11, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 4 | Aug 21, 2026 | Aug 21, 2026 | |
| 8-K | Aug 17, 2026 | Aug 17, 2026 | |
| 10-Q | Aug 11, 2026 | Aug 11, 2026 | |
| 8-K | Aug 11, 2026 | Aug 11, 2026 | |
| ARS | Jul 10, 2026 | Jul 10, 2026 | |
| DEF 14A | Jul 10, 2026 | Jul 10, 2026 | |
| PRE 14A | Jun 29, 2026 | Jun 29, 2026 | |
| 8-K | Jun 12, 2026 | Jun 12, 2026 |
Competitors
Who does Aardvark Therapeutics, Inc. Common Stock compete with?
Open similar companies to compare their filings and price history.
Competitors
Peer companies in the same sector
Questions
Filing questions
Common questions about AARD's filings, answered from its disclosures.
What is the latest AARD filing?
The latest filing shown is 4 dated Oct 8, 2026.
How many recent filings does AARD have?
Intrinsic Alpha currently shows 20 recent filings for AARD.
Continue the stock analysis
Jump to another research area for this company.